Active and passive case-finding in tuberculosis-affected households in Peru: a 10-year prospective cohort study
File(s)1-s2.0-S1473309918307539-main.pdf (2.11 MB)
Published version
Author(s)
Type
Journal Article
Abstract
Background. Active case finding (ACF) among contacts of patients with tuberculosis is a global health priority, but the effects of ACF compared to passive case finding (PCF) are poorly characterised. We assessed the contribution of ACF versus PCF to tuberculosis detection among contacts and compared sex and disease characteristics between contacts diagnosed through these strategies.
Methods. In shantytowns in Callao, Peru, we identified index patients with tuberculosis and followed their contacts aged ≥15 years for tuberculosis for a median 10 years. All were offered free programmatic ACF involving sputum smear microscopy and clinical evaluation. Additionally, all contacts were offered intensified ACF with sputum smear and culture testing monthly for six months and then once every four years. PCF at local health facilities was ongoing throughout follow up.
Findings. 8.7% (232/2,666) of contacts were diagnosed with tuberculosis: a two-year cumulative risk of 4.6% and overall incidence of 0.98/100 person-years. 23% (53/232) were diagnosed through ACF and 77% (179/232) through PCF. During the first six months, 45% (23/51) were diagnosed through ACF and 55% (28/51) through PCF. Contacts diagnosed through ACF versus PCF were more frequently female (68% [36/53] versus 47% [85/179], p=0.009); had a shorter symptom duration (25% [9/36] had symptoms for less than 15 days versus 8% [10/127], p=0.03); and were more likely to be sputum smear negative (62% [33/53] versus 35% [62/179], p<0.001).
Interpretation. Although ACF made an important contribution to tuberculosis detection among contacts, PCF detected the majority of the tuberculosis burden. Compared to PCF, ACF was equitable, diagnosed tuberculosis earlier and usually before it became sputum smear positive, and revealed a high burden of undetected tuberculosis among women.
Methods. In shantytowns in Callao, Peru, we identified index patients with tuberculosis and followed their contacts aged ≥15 years for tuberculosis for a median 10 years. All were offered free programmatic ACF involving sputum smear microscopy and clinical evaluation. Additionally, all contacts were offered intensified ACF with sputum smear and culture testing monthly for six months and then once every four years. PCF at local health facilities was ongoing throughout follow up.
Findings. 8.7% (232/2,666) of contacts were diagnosed with tuberculosis: a two-year cumulative risk of 4.6% and overall incidence of 0.98/100 person-years. 23% (53/232) were diagnosed through ACF and 77% (179/232) through PCF. During the first six months, 45% (23/51) were diagnosed through ACF and 55% (28/51) through PCF. Contacts diagnosed through ACF versus PCF were more frequently female (68% [36/53] versus 47% [85/179], p=0.009); had a shorter symptom duration (25% [9/36] had symptoms for less than 15 days versus 8% [10/127], p=0.03); and were more likely to be sputum smear negative (62% [33/53] versus 35% [62/179], p<0.001).
Interpretation. Although ACF made an important contribution to tuberculosis detection among contacts, PCF detected the majority of the tuberculosis burden. Compared to PCF, ACF was equitable, diagnosed tuberculosis earlier and usually before it became sputum smear positive, and revealed a high burden of undetected tuberculosis among women.
Date Issued
2019-05
Date Acceptance
2018-11-29
Citation
Lancet Infectious Diseases, 2019, 19 (5), pp.519-528
ISSN
1473-3099
Publisher
Elsevier
Start Page
519
End Page
528
Journal / Book Title
Lancet Infectious Diseases
Volume
19
Issue
5
Copyright Statement
© 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/)
License URL
Sponsor
Medical Research Council (MRC)
Wellcome Trust
Identifier
https://www.sciencedirect.com/science/article/pii/S1473309918307539?via%3Dihub
Grant Number
MR/K007467/1
201251/Z/16/Z
Subjects
Science & Technology
Life Sciences & Biomedicine
Infectious Diseases
SUSCEPTIBILITY
TRANSMISSION
DIAGNOSIS
IMPACT
Microbiology
1103 Clinical Sciences
1108 Medical Microbiology
Publication Status
Published
Date Publish Online
2019-03-22